Orchestra BioMed today announced a slew of agreements, including a strategic collaboration with Medtronic (NYSE:MDT). The global strategic collaboration will progress the development of Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy (CNT) as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. Additionally, Orchestra BioMed closed a $110 million Series D […]
Cardiovascular
Acutus completes first closing in left-heart access portfolio sale to Medtronic
Acutus Medical (Nasdaq:AFIB) announced today that it completed the first of two closings in its portfolio sale to Medtronic (NYSE:MDT). Carlsbad, California–based Acutus announced in April that it entered into a definitive agreement to sell its left-heart access portfolio to Medtronic for $50 million. The company’s left-heart access portfolio includes its AcQCross line of sheath-compatible septal […]
Advanced NanoTherapies closes $7.2M Series A for drug-coated balloon
Advanced NanoTherapies announced today that it closed an oversubscribed Series A equity financing round. Los Gatos, California-based Advanced NanoTherapies, which develops the SirPlux Duo drug-coated balloon (DCB) for treating de novo coronary artery disease (CAD) lesions, has now raised $12.5 million in total since September 2020. Get the full story at our sister site, Drug […]
FDA clears Acutus’ AcQCross system for use with Boston Scientific’s Watchman
Acutus Medical (Nasdaq:AFIB) announced today that it launched an expanded suite of left-heart access products. Following expanded FDA clearance, Acutus launched the suite to now include the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Boston Scientific Watchman left atrial appendage closure device. Carlsbad, California-based Acutus designed the AcQCross […]
Elucid raises $27M for heart disease diagnosis software
Elucid announced that it closed a Series B financing round with proceeds totaling $27 million. Boston-based Elucid’s Series B round was led by an undisclosed strategic investor. A new investor, Biovision Ventures, participated, as did existing investors MedTex Ventures, IAG Capital, Bold Brain Ventures and BlueStone Venture Partners. Elucid designed its FDA-cleared and CE-marked software […]
BioSig expects to raise $3.5M from public offering
BioSig Technologies (Nasdaq:BSGM) announced today that it priced a previously announced public offering at $3.5 million. Westport, Connecticut–based BioSig’s best efforts, underwritten public offering totals up to 4,666,667 shares of its common stock, $0.001 par value per share, at a price to the public of $0.75 per share, bringing the gross proceeds to $3.5 million. […]
Another Medtronic HVAD recall is serious
A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving HeartWare Ventricular Assist Device pumps still implanted in patients. The FDA today designated a Medtronic recall involving the HVADs as Class I, the most serious level. It’s the second Class I recall designation for the HVADs this […]
Endologix reports positive results from percutaneous bypass trial
Endologix announced today that 12-month results from a trial of its Detour system demonstrated a low rate of complications. Irvine, California-based Endologix’s Detour 2 FDA investigational device exemption (IDE) study was designed to evaluate the safety and effectiveness of the Detour system for percutaneous bypass in the treatment of long-segment femoropopliteal disease. Get the full story […]
Vektor Medical names Rob Krummen as CEO
Vektor Medical this week announced that it appointed Rob Krummen as CEO. Krummen previously served as president and chief operating officer of the San Diego-based company. He was responsible for the clinical, regulatory, engineering and operations and will continue to oversee the efforts while growing the company’s commercial and sales teams as CEO. The company […]
Teleflex enrolls first patient in vascular closure device study
Teleflex (NYSE:TFX) announced today that it enrolled the first patient in a clinical study of its Manta vascular closure device. In the study, Wayne, Pennsylvania-based Teleflex intends to demonstrate the safety of Manta ultrasound-guided closure without dependence on the pre-procedural depth locator measurements. According to a news release, the study will enroll up to 150 […]
Artio Medical adds $28M in oversubscribed Series A
Artio Medical announced that it picked up an additional $28 million in an oversubscribed financing round. The oversubscribed Series A2 and Series A3 financings bring the Prairie Village, Kansas-based company’s total amount raised in the round to $74 million. According to a news release, Artio Medical plans to use the funds to support its U.S. […]
